Mega Lifesciences PCL (BKK:MEGA) Operating Cash Flow per Share : ฿2.59 (TTM As of Mar. 2025)

View and export this data going back to 2013. Start your Free Trial

What is Mega Lifesciences PCL Operating Cash Flow per Share?

Mega Lifesciences PCL's operating cash flow per share for the three months ended in Mar. 2025 was ฿0.46. Mega Lifesciences PCL's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2025 was ฿2.59.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Mega Lifesciences PCL was 4.20% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -4.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 7.60% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 15.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Mega Lifesciences PCL's Operating Cash Flow per Share or its related term are showing as below:

BKK:MEGA' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -4.2 Med: 14.4 Max: 44
Current: -4.2

During the past 13 years, Mega Lifesciences PCL's highest 3-Year average Operating Cash Flow per Share Growth Rate was 44.00% per year. The lowest was -4.20% per year. And the median was 14.40% per year.

BKK:MEGA's 3-Year OCF Growth Rate is ranked worse than
67.95% of 780 companies
in the Drug Manufacturers industry
Industry Median: 8.85 vs BKK:MEGA: -4.20

Mega Lifesciences PCL Operating Cash Flow per Share Historical Data

The historical data trend for Mega Lifesciences PCL's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mega Lifesciences PCL Operating Cash Flow per Share Chart

Mega Lifesciences PCL Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Operating Cash Flow per Share

Get a 7-Day Free Trial

1.87

3.13

2.29

2.21

2.75

Mega Lifesciences PCL Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Operating Cash Flow per Share	Get a 7-Day Free Trial															0.63	1.21	-0.01	0.92	0.46

Competitive Comparison of Mega Lifesciences PCL's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Mega Lifesciences PCL's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mega Lifesciences PCL's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mega Lifesciences PCL's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Mega Lifesciences PCL's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Mega Lifesciences PCL Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Mega Lifesciences PCL's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )	=	Cash Flow from Operations (A: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2024 )
	=	2401.377	/	871.870
	=	2.75

Mega Lifesciences PCL's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Mar. 2025 )	=	Cash Flow from Operations (Q: Mar. 2025 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2025 )
	=	397.827	/	865.069
	=	0.46

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿2.59

Mega Lifesciences PCL Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Mega Lifesciences PCL's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Mega Lifesciences PCL Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mega Lifesciences PCL (BKK:MEGA) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

MEGA-R:Thailand

Address

Debaratna Road, 909, Ample Tower, 9th Floor, Bangna Nuea, Bangna, Bangkok, THA, 10260

Website

https://www.megawecare.com

Mega Lifesciences PCL manufactures and sells through independent distributors of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods as well as provides distribution services relating to such products. The company's product portfolio consists of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods. Its segments include Brands in which goods are manufactured and sold under brands owned by the group; Distribution in which the group provides logistical and marketing services for goods trading purposes and sale of goods manufactured by third parties; and OEM.

Mega Lifesciences PCL Headlines

No Headlines